INHIBITORY FACTORS OF LYMPHOCYTE-TRANSFORMATION IN SERA FROM PATIENTS WITH MINIMAL CHANGE NEPHROTIC SYNDROME

  • 1 January 1980
    • journal article
    • research article
    • Vol. 13  (6) , 271-276
Abstract
The specificity and relation to disease activity of serum inhibitors of lymphocyte function in minimal change nephrotic syndrome (MCNS) were investigated. Sera from 21 children with MCNS were evaluated for their effects on blast transformation of normal human lymphocytes after stimulation with E-PHA [erythroagglutinating phytohemagglutinin], ConA [concanavalin A], PWM [pokeweed mitogen] or allogeneic cell surface antigens (mixed lymphocyte cultures; MLC). Sera from patients in relapse on no medication (n = 12), in relapse on steroids (n = 5) and in remission on steroids (n = 7) were significantly more inhibitory than sera from patients in late remission off steroids (n = 14), both in mitogen-induced blast transformation and in MLC. Sera from 8 children with other forms of nephrotic syndrome exhibited the same degree of inhibition of E-PHA, ConA and PWM-induced mitogenesis, but significantly less inhibition of MLC when compared to 12 MCNS patients in untreated relapse. Serum inhibition of mitogen-induced blast transformation is not specific for MCNS, but occurs in other forms of nephrotic syndrome as well. Sera from MCNS patients does selectively inhibit MLC. The inhibitory activity of MCNS sera for both mitogen and cell surface antigen stimulation correlates with the course of the disease.

This publication has 0 references indexed in Scilit: